Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Goodwin Procter represented Gritstone bio, Inc. in the offering, and Cooley represented the underwriters. Gritstone bio, Inc. (Nasdaq: GRTS) announced the pricing of...
You must be a Standard 1 Year member to access this content.
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Morgan Lewis and Marathon Capital advised Ashtrom Renewable Energy. Allen & Overy advised Stonehenge Capital. Paul Hastings LLP advised the lead arrangers and joint bookrunners. Ashtrom...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins and Husch Blackwell advised Swift Current Energy, and Paul Hastings advised the lenders. Swift Current Energy announced that it has closed project financing...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP is serving as legal counsel to Neurogene Inc. and Fenwick & West LLP is serving as legal counsel to Neoleukin Therapeutics,...
You must be a Standard 1 Year member to access this content.
Paul Hastings represented Spearmint as borrower and its subsidiaries as guarantors. Holland and Knight served as legal counsel for Aiga. Spearmint Energy announced the close of a...
You must be a Standard 1 Year member to access this content.
Fenwick represented Day One Biopharmaceuticals, Inc. on the offering, while Cooley LLP represented the underwriters. Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company focused...
You must be a Standard 1 Year member to access this content.
Fenwick represented Morphic Holding, Inc. on the deal. Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment...
You must be a Standard 1 Year member to access this content.
Fenwick represented The Arena Group on the deal. The Arena Group (NYSE American: AREN), a tech-powered media company home to more than 240 brands, including Sports...
You must be a Standard 1 Year member to access this content.
